Tenaya Therapeutics Inc.

TNYA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.68

+$0.01 (+0.92%)

Sep 22, 2026, 12:52 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-90.6M	-111.13M	-124.08M	-123.67M	-72.72M	-38.4M
Depreciation & Amortization	8.85M	8.47M	8.69M	6.47M	2.96M	2.48M
Stock-Based Compensation	13.05M	16.5M	15.31M	11.47M	2.95M	741K
Other Working Capital	-1.03M	-7.35M	-2.37M	-2.51M	-3.86M	-376K
Other Non-Cash Items	2.9M	3.59M	3.66M	2.16M	1.26M	-42K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-2.46M	-7.93M	-5.65M	-849K	4.74M	-234K
Operating Cash Flow	-68.26M	-90.5M	-102.07M	-104.42M	-60.81M	-35.45M
Capital Expenditures	-618K	-1.03M	-1.24M	-20.63M	-25.12M	-9.76M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-87.07M	-56.64M	-140.48M	-213.44M	n/a
Sales Maturities Of Investments	56.7M	89.21M	106.62M	244.75M	n/a	2.75M
Other Investing Acitivies	n/a	17K	-25K	8K	n/a	n/a
Investing Cash Flow	56.08M	1.13M	48.72M	83.65M	-238.56M	-7.01M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-13K	-1K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	987K	181K	380K	461K	34K
Financial Cash Flow	108.41M	47.75M	4.05M	77.77M	208.97M	147.27M
Net Cash Flow	96.22M	-41.62M	-49.31M	57M	-90.41M	104.81M
Free Cash Flow	-68.88M	-91.53M	-103.31M	-125.05M	-85.93M	-45.21M
Adj. Free Cash Flow	-81.93M	-108.03M	-118.62M	-136.52M	-88.88M	-45.95M
Maintenance CapEx	-618K	-1.03M	-1.24M	-6.47M	-2.96M	-2.48M
Growth CapEx	n/a	n/a	n/a	-14.16M	-22.16M	-7.28M
Owner Earnings	-68.88M	-91.53M	-103.31M	-110.89M	-63.77M	-37.93M